SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
251 hedge funds and large institutions have $4.01B invested in SALIX PHARMACEUTICALS LTD DEL in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 92 increasing their positions, 97 reducing their positions, and 32 closing their positions.
175% more call options, than puts
Call options by funds: $63.1M | Put options by funds: $23M
28% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 32
3% more funds holding
Funds holding: 243 → 251 (+8)
1% more capital invested
Capital invested by funds: $3.96B → $4.01B (+$49.4M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 97
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$86.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$48.4M |
| 3 |
VAM
Visium Asset Management
New York
|
+$37.9M |
| 4 |
PC
PointState Capital
New York
|
+$36.5M |
| 5 |
TA
Teachers Advisors
New York
|
+$29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Herndon Capital Management
Atlanta,
Georgia
|
-$87M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$27.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$24.1M |
| 4 |
Two Sigma Investments
New York
|
-$23.9M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$20.1M |
SLXP Hedge Fund Activity: Q3 2013 in Review
251 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q3 2013, worth a combined $4.01B — up 1.2% from $3.96B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new SLXP positions and 32 closed out — a net gain of 9 holders — while 92 added to existing stakes and 97 trimmed.
The largest buyer was TIAA CREF Investment Management, adding an estimated $86.2M. The largest seller was Herndon Capital Management, cutting an estimated $87M.
- 251 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q3 2013, up from 243 in Q2 2013.
- Funds reported $4.01B of SALIX PHARMACEUTICALS LTD DEL stock for Q3 2013, up 1.2% quarter-over-quarter.
- 41 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q3 2013 and 32 closed out, a net change of +9 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q3 2013 was TIAA CREF Investment Management, an estimated $86.2M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q3 2013 was Herndon Capital Management, an estimated $87M sold.
Based on aggregated 13F filings for Q3 2013.